Glycogen synthase kinase 3β (GSK3B); NF-κB; nuclear factor of κ light polypeptide gene enhancer in B cells 2 p49/p100 (NFKB2; p52) BriefCommunication Pages: 279 - 279
AMPA 1 glutamate receptor (GRIA1; GLUR1); NMDA receptor NR1 subtype (GRIN1; NR1); proteasome BriefCommunication Pages: 285 - 285
CXC chemokine receptor 6 (CXCR6); chemokine CXC motif ligand 16 (CXCL16) BriefCommunication Pages: 286 - 286
Ex vivo microfluidic measurement of blood conductance to determine disease severity in patients with sickle cell disease BriefCommunication Pages: 289 - 289
High throughput sequencing platform for small molecule cancer drug discovery BriefCommunication Pages: 290 - 290
Probes for measuring the activity of multiple cancer-associated kinases in tissue lysates BriefCommunication Pages: 291 - 291
Catalyst-based, site-selective oxidation of methyl carbons in hydroxy-γ-methyl or keto-γ-methyl structures for natural product synthesis BriefCommunication Pages: 293 - 293
Mouse model of corticosterone-induced post-traumatic stress disorder (PTSD) BriefCommunication Pages: 294 - 294
Crystal structure of dihydropteroate synthase bound to sulfonamide antibiotics BriefCommunication Pages: 295 - 295
Using sonic hedgehog homolog (SHH)-treated engineered blood vessels to improve bone formation BriefCommunication Pages: 296 - 296
Methylation of ataxia telangiectasia mutated ( ATM ) as a marker for breast cancer risk BriefCommunication Pages: 297 - 297